La Trobe

Striated muscle: an inadequate soil for cancers

Download (2.74 MB)
journal contribution
posted on 2024-11-26, 02:45 authored by Alastair Saunders, RE Thomson, CA Goodman, Robin AndersonRobin Anderson, P Gregorevic
Many organs of the body are susceptible to cancer development. However, striated muscles—which include skeletal and cardiac muscles—are rarely the sites of primary cancers. Most deaths from cancer arise due to complications associated with the development of secondary metastatic tumours, for which there are few effective therapies. However, as with primary cancers, the establishment of metastatic tumours in striated muscle accounts for a disproportionately small fraction of secondary tumours, relative to the proportion of body composition. Examining why primary and metastatic cancers are comparatively rare in striated muscle presents an opportunity to better understand mechanisms that can influence cancer cell biology. To gain insights into the incidence and distribution of muscle metastases, this review presents a definitive summary of the 210 case studies of metastasis in muscle published since 2010. To examine why metastases rarely form in muscles, this review considers the mechanisms currently proposed to render muscle an inhospitable environment for cancers. The “seed and soil” hypothesis proposes that tissues’ differences in susceptibility to metastatic colonization are due to differing host microenvironments that promote or suppress metastatic growth to varying degrees. As such, the “soil” within muscle may not be conducive to cancer growth. Gaining a greater understanding of the mechanisms that underpin the resistance of muscles to cancer may provide new insights into mechanisms of tumour growth and progression, and offer opportunities to leverage insights into the development of interventions with the potential to inhibit metastasis in susceptible tissues.

Funding

This work was supported by a Research Training Program Scholarship from the Australian Government and a PhD top-up scholarship from Tour de Cure (RSP-055-FY2024) awarded to A.A.E.S., Project Grants (9300 and 10057) from the CASS Foundation awarded to R.E.T., a Pioneering Research Grant from Tour de Cure awarded to P.G. and R.L.A. (RSP-251-FY2023), and an Investigator Grant (APP2017070) from the National Health and Medical Research Council (Australia) awarded to P.G.

History

Publication Date

2024-12-01

Journal

Cancer and Metastasis Reviews

Volume

43

Issue

4

Pagination

17p. (p. 1511-1527)

Publisher

Springer Nature

ISSN

0167-7659

Rights Statement

© The Author(s) 2024 This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Usage metrics

    Journal Articles

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC